tiprankstipranks
CytomX Therapeutics announces first patient dosed with CX-801
PremiumThe FlyCytomX Therapeutics announces first patient dosed with CX-801
4M ago
CytomX Therapeutics files $250M mixed securities shelf
Premium
The Fly
CytomX Therapeutics files $250M mixed securities shelf
5M ago
CytomX Therapeutics reports Q2 EPS (8c), consensus (14c)
Premium
The Fly
CytomX Therapeutics reports Q2 EPS (8c), consensus (14c)
5M ago
CytomX upgraded on pancreatic cancer data at Piper Sandler
PremiumThe FlyCytomX upgraded on pancreatic cancer data at Piper Sandler
7M ago
CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
7M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
7M ago
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
PremiumThe FlyCytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
8M ago
CytomX Therapeutics options imply 56.8% move in share price post-earnings
Premium
The Fly
CytomX Therapeutics options imply 56.8% move in share price post-earnings
8M ago
CytomX Therapeutics, Merck enter CX-801 trial collaboration
Premium
The Fly
CytomX Therapeutics, Merck enter CX-801 trial collaboration
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100